Apoptotic activator p53 represses CLU promoter activity and transcription in the MCF-7 breast cancer and the HCT 116 colon cancer cell lines, resulting in reduced levels of secreted clusterin (Criswell et al., 2003). The gene discussed is CLU; the disease is breast carcinoma.